NCT04716504

Brief Summary

Prolonged mechanical ventilation has been shown to induce diaphragm dysfunction. Temporary diaphragm pacing is an interesting lead to halt or slow diaphragm dysfunction. A detailed description of the distal portion of the phrenic nerve would be the start for developing a new surgical approach for diaphragm pacing. Its in that perspective that we are launching a clinical observational study of the distal portion of the phrenic nerve in patients who undergo minimally invasive thoracic surgey. We hypothetize that the density of the fatty tissue surrounding the distal portion of the phrenic nerve might influence efficiency of the electrode during diaphragm pacing. The objective of this study is to find a correlation between the amount of fatty tissue around the nerve and the body mass index of individuals.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
54

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jan 2021

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 15, 2021

Completed
5 days until next milestone

First Posted

Study publicly available on registry

January 20, 2021

Completed
3 days until next milestone

Study Start

First participant enrolled

January 23, 2021

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2021

Completed
Last Updated

October 25, 2021

Status Verified

October 1, 2021

Enrollment Period

3 months

First QC Date

January 15, 2021

Last Update Submit

October 22, 2021

Conditions

Keywords

Diaphragm pacingphrenic nerve-flowing portion

Outcome Measures

Primary Outcomes (1)

  • correlation between body mass index and fatty tissue surrounding phrenic nerve

    During the initial phase of the surgical intervention, the surgeons would explore the thoracic cavity for potential contra-indications of any lung resection. While doing so, they would identify the phrenic nerve in order to prevent any lesions. During that particular moment, the recording option on the camera would be activated to register exploration of the distal portion of the phrenic nerve before it ends in the diaphragm. Two independent observers would review this video and classify the phrenic nerve depending on the amount of fatty tissue surrounding it.

    Day 0

Secondary Outcomes (1)

  • Inter-Observer Variability

    Up to 3 weeks

Study Arms (1)

Minimally invasive surgery for a benign or malignant pulmonary lesion.

The patients will be divided in three categories depending on the Body Mass Index: * Category 1: 18,5 kg/m2 \< BMI \< 24,9 kg/m2 -Category 2: 25 kg/m2 \< BMI \< 29,9 kg/m2 / * Category 3: 30,0 kg/m2 \< BMI \< 34,9 kg/m2

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study population will be patients who consult for a benign or malignant pulmonary lesion. Resection of the lesion would have to be done by a minimally invasive approach (video-assisted thoracoscopic surgery or robotic-assisted thoracoscopic surgery).

You may qualify if:

  • patients older than 18 years-old and not under a protection measure
  • patients undergoing lung resection for a malignant or benign lesion
  • surgical approach by minimally invasive technique (video-assisted thoracoscopic surgery or robotic-assisted thoracoscopic surgery)

You may not qualify if:

  • surgical approach by thoracotomy
  • intense pleural adhesions between the lung parenchyma and the mediastinal pleura.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Tenon Hospital, Service : Chirurgie Vasculaire et Thoracique

Paris, 75020, France

Location

Study Officials

  • Jalal Assouad, PUPH

    Assistance Publique - Hôpitaux de Paris

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 15, 2021

First Posted

January 20, 2021

Study Start

January 23, 2021

Primary Completion

April 30, 2021

Study Completion

April 30, 2021

Last Updated

October 25, 2021

Record last verified: 2021-10

Data Sharing

IPD Sharing
Will not share

Locations